(Q33551154)

28 July 2017

Generating heparan sulfate saccharide libraries for glycomics applications. (English)

1 reference

28 July 2017

Edwin A Yates

3

0 references

author name string

Andrew K Powell

series ordinal

1

1 reference

28 July 2017

Yassir A Ahmed

series ordinal

2

1 reference

28 July 2017

Jeremy E Turnbull

series ordinal

4

1 reference

28 July 2017

8 April 2010

1 reference

28 July 2017

1 reference

28 July 2017

5

1 reference

28 July 2017

5

1 reference

28 July 2017

821-833

1 reference

https://scigraph.springernature.com/pub.10.1038/nprot.2010.17

28 July 2017

0 references

cites work

Heparin-protein interactions

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

The specificity of interactions between proteins and sulfated polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Mapping and quantification of the major oligosaccharide components of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Oligosaccharide mapping of heparan sulphate by polyacrylamide-gradient-gel electrophoresis and electrotransfer to nylon membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Heparan sulphate proteoglycans fine-tune mammalian physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

The heparanome and regulation of cell function: structures, functions and challenges

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

31 March 2020

12 December 2020

Heparan sulfate-protein interactions: therapeutic potential through structure-function insights.

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Interactions between heparan sulfate and proteins: the concept of specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Enzymatic synthesis of glycosaminoglycan heparin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Heparin structure and interactions with basic fibroblast growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

A molecular mechanism for the heparan sulfate dependence of slit-robo signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Capillary electrophoretic separation of heparin oligosaccharides under conditions amenable to mass spectrometric detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Liquid Chromatography/Mass Spectrometry Sequencing Approach for Highly Sulfated Heparin-derived Oligosaccharides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Heparin sequencing using enzymatic digestion and ESI-MSn with HOST: a heparin/HS oligosaccharide sequencing tool

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Software tool for the structural determination of glycosaminoglycans by mass spectrometry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

On-line separations combined with MS for analysis of glycosaminoglycans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Size-fractionated heparins have differential effects on human neutrophil function in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Conformational transitions induced in heparin octasaccharides by binding with antithrombin III.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Enzymatic redesigning of biologically active heparan sulfate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Isolation and characterization of heparan sulfate from various murine tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Rapid purification and high sensitivity analysis of heparan sulfate from cells and tissues: toward glycomics profiling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Examination of the substrate specificity of heparin and heparan sulfate lyases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Formation of anhydrosugars in the chemical depolymerization of heparin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Evidence of a selective free radical degradation of heparin, mediated by cupric ion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Solution properties of high-molar-mass hyaluronans: the biopolymer degradation by ascorbate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

A strategy for rapid sequencing of heparan sulfate and heparin saccharides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Advances in the separation, sensitive detection, and characterization of heparin and heparan sulfate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2010.17

Conformation of heparin pentasaccharide bound to antithrombin III

31 March 2020

1 reference

12 December 2020

Saccharide microarrays for high-throughput interrogation of glycan-protein binding interactions

1 reference

12 December 2020

Labelling heparan sulphate saccharides with chromophore, fluorescence and mass tags for HPLC and MS separations

1 reference

12 December 2020

Combined strong anion-exchange HPLC and PAGE approach for the purification of heparan sulphate oligosaccharides

1 reference

12 December 2020

Microbial adherence to and invasion through proteoglycans

1 reference

12 December 2020

Identifiers

DOI

10.1038/NPROT.2010.17

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference